| Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer S Dhar, A Kumar, A Zhang, Xu and Levenson Oncotarget 6 (29), 27214-27226, 2015 | 158 | 2015 |
| Resveratrol and prostate cancer: promising role for microRNAs S Dhar, C Hicks, AS Levenson Molecular nutrition & food research 55 (8), 1219-1229, 2011 | 143 | 2011 |
| Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer S Dhar, A Kumar, K Li, G Tzivion, AS Levenson Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (2), 265-275, 2015 | 135 | 2015 |
| Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer K Li, SJ Dias, AM Rimando, S Dhar, CS Mizuno, AD Penman, JR Lewin, ... PloS one 8 (3), e57542, 2013 | 107 | 2013 |
| Trimethoxy‐R esveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts SJ Dias, K Li, AM Rimando, S Dhar, CS Mizuno, AD Penman, ... The Prostate 73 (11), 1135-1146, 2013 | 93 | 2013 |
| γδ T cells in cancer immunotherapy: current status and future prospects S Chiplunkar, S Dhar, D Wesch, D Kabelitz Immunotherapy 1 (4), 663-678, 2009 | 70 | 2009 |
| Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer S Dhar, A Kumar, L Zhang, AM Rimando, JM Lage, JR Lewin, A Atfi, ... Oncotarget 7 (14), 18469, 2016 | 66 | 2016 |
| Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer A Kumar, S Dhar, AM Rimando, JM Lage, JR Lewin, X Zhang, ... Annals of the New York Academy of Sciences 1348 (1), 1-9, 2015 | 60 | 2015 |
| Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells S Dhar, SV Chiplunkar Cancer immunity 10 (1), 2010 | 57 | 2010 |
| Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression NA Butt, A Kumar, S Dhar, AM Rimando, I Akhtar, JC Hancock, JM Lage, ... Cancer medicine 6 (11), 2673-2685, 2017 | 55 | 2017 |
| Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans SJ Dias, X Zhou, M Ivanovic, MP Gailey, S Dhar, L Zhang, Z He, ... Scientific reports 3 (1), 2331, 2013 | 50 | 2013 |
| MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness LAS Dhar S, Kumar A, Gomez CR, Akhtar I, Hancock JC, Lage JM, Pound CR FEBS Letters 591 (6), 924-933, 2017 | 46 | 2017 |
| Stilbenes inhibit androgen receptor expression in 22Rv1 castrate-resistant prostate cancer cells A Kumar, SY Lin, S Dhar, AM Rimando, AS Levenson Journal of Medicinally Active Plants 3 (1-4), 2014 | 22 | 2014 |
